What is Matreya?
Matreya operates within the life sciences sector, specializing in the provision of critical research materials. Their product catalog includes assay kits, antibodies, biochemicals, and proteins, essential components for scientific inquiry. Beyond product supply, Matreya extends its expertise through contract research services, offering tailored support for diverse research initiatives. The company's commitment to delivering high-quality materials and services positions it as a key supplier for academic institutions, biotechnology firms, and pharmaceutical companies engaged in laboratory and research applications.
How much funding has Matreya raised?
Matreya has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Matreya?
The substantial large-scale late-stage funding Matreya has attracted signals a pivotal moment for the company. This capital infusion is expected to fuel strategic growth initiatives, potentially involving the expansion of its product lines, enhancement of its contract research capabilities, and broader market penetration. The recent strategic investment suggests confidence from backers in Matreya's long-term vision and its capacity to scale operations effectively, likely focusing on advancing its offerings and solidifying its competitive edge in the scientific supply and research services domain.
See full Matreya company page
